| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.88▲ | 4.92▼ | 4.94▼ | 4.83▲ | 4.64▲ |
| MA10 | 4.93▼ | 4.95▼ | 4.95▼ | 4.78▲ | 4.40▲ |
| MA20 | 4.94▼ | 4.95▼ | 4.85▲ | 4.67▲ | 5.54▼ |
| MA50 | 4.92▼ | 4.84▲ | 4.81▲ | 4.45▲ | 7.97▼ |
| MA100 | 4.85▲ | 4.79▲ | 4.75▲ | 5.77▼ | 11.78▼ |
| MA200 | 4.80▲ | 4.63▲ | 4.34▲ | 7.77▼ | 321.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.014▼ | 0.003▲ | 0.034▲ | 0.254▲ |
| RSI | 46.214▼ | 50.090▲ | 52.989▲ | 54.962▲ | 40.719▼ |
| STOCH | 15.733▼ | 32.500 | 52.585 | 70.436 | 49.508 |
| WILL %R | -65.000 | -65.000 | -30.233 | -35.593 | -71.400 |
| CCI | -89.599 | -115.951▼ | -25.517 | 120.562▲ | 25.623 |
|
Thursday, June 26, 2025 08:19 AM
Avalo Therapeutics, Inc. (NASDAQ:AVTX), incorporated in 2001, operates as a clinical-stage biotechnology company that develops treatments for immune dysregulation in the United States.
|
|
Wednesday, June 18, 2025 04:00 AM
Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the appointment of Rita Jain, M.D. to its Board of ...
|
|
Monday, May 12, 2025 04:31 AM
AVALO THERAPEUTICS posted quarterly earnings results on Monday, May 12th.The company reported earnings of -$1.25 per share, beating estimates of -$1.41 by $0.16. The company also reported revenue ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/25 | 4.98 | 5.05 | 4.797 | 4.84 | 52,821 |
| 30/06/25 | 4.85 | 5.00 | 4.76 | 4.99 | 70,881 |
| 27/06/25 | 4.78 | 4.85 | 4.55 | 4.78 | 93,801 |
| 26/06/25 | 4.78 | 4.828 | 4.53 | 4.76 | 52,797 |
| 25/06/25 | 5.02 | 5.02 | 4.50 | 4.79 | 264,292 |
| 24/06/25 | 4.92 | 4.95 | 4.73 | 4.95 | 69,112 |
| 23/06/25 | 4.55 | 4.90 | 4.55 | 4.79 | 52,240 |
| 20/06/25 | 4.81 | 4.92 | 4.5817 | 4.64 | 33,833 |
| 18/06/25 | 4.51 | 4.898 | 4.47 | 4.76 | 41,204 |
| 17/06/25 | 4.60 | 4.77 | 4.46 | 4.47 | 66,739 |
|
|
||||
|
|
||||
|
|